Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Eli Lilly and Company(LLY) | 0 | 94,887 | +94,887 | $0 | $78.37M | 22.98% | +$78.37M |
| Soleno Therapeutics Inc | 494,424 | 498,473 | +4,049 | $22.22M | $35.62M | 10.44% | +$13.39M |
| Verona Pharma PlcADS | 255,318 | 538,488 | +283,170 | $11.86M | $34.19M | 10.03% | +$22.33M |
| Intra-Cellular Therapies Inc | 219,719 | 219,719 | 0 | $18.35M | $28.99M | 8.50% | +$10.63M |
| Insmed Incorporated(INSM) | 167,939 | 318,239 | +150,300 | $11.59M | $24.28M | 7.12% | +$12.68M |
| Merus N V | 463,840 | 424,640 | -39,200 | $19.50M | $17.87M | 5.24% | -$1.63M |
| Protagonist Therapeutics Inc | 293,851 | 333,851 | +40,000 | $11.34M | $16.15M | 4.73% | +$4.80M |
| Arcellx Inc COMMON STOCK | 229,785 | 229,085 | -700 | $17.62M | $15.03M | 4.41% | -$2.59M |
| AstraZeneca PLCADR(AZN) | 190,752 | 190,752 | 0 | $12.50M | $14.02M | 4.11% | +$1.52M |
| Boston Scientific Corporation(BSX) | 0 | 129,700 | +129,700 | $0 | $13.08M | 3.84% | +$13.08M |
| Quest Diagnostics Incorporated(DGX) | 0 | 56,717 | +56,717 | $0 | $9.60M | 2.81% | +$9.60M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 56,400 | 28,600 | -27,800 | $13.27M | $7.72M | 2.26% | -$5.55M |
| argenx SEADR(ARGX) | 11,311 | 11,311 | 0 | $6.96M | $6.69M | 1.96% | -$261.7K |
| Nuvalent Inc | 204,045 | 90,745 | -113,300 | $15.97M | $6.44M | 1.89% | -$9.54M |
| Scholar Rock Holding Corporation(SRRK) | 0 | 172,185 | +172,185 | $0 | $5.54M | 1.62% | +$5.54M |
| Revolution Medicines, Inc.(RVMD) | 284,190 | 104,190 | -180,000 | $12.43M | $3.68M | 1.08% | -$8.75M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 50,000 | 50,000 | 0 | $2.80M | $2.65M | 0.78% | -$150.5K |
| Springworks Therapeutics Inc | 53,930 | 53,930 | 0 | $1.95M | $2.38M | 0.70% | +$431.4K |
| Viking Therapeutics, Inc.(VKTX) | 90,279 | 90,279 | 0 | $3.63M | $2.18M | 0.64% | -$1.45M |
| Viridian Therapeutics, Inc.(VRDN) | 100,000 | 160,000 | +60,000 | $1.92M | $2.16M | 0.63% | +$239.8K |
| TG Therapeutics, Inc.(TGTX) | 54,515 | 54,515 | 0 | $1.64M | $2.15M | 0.63% | +$508.6K |
| Intuitive Surgical, Inc.(ISRG) | 0 | 3,500 | +3,500 | $0 | $1.73M | 0.51% | +$1.73M |
| EyePoint, Inc.(EYPT) | 216,700 | 316,700 | +100,000 | $1.61M | $1.72M | 0.50% | +$102.1K |
| Neurocrine Biosciences, Inc.(NBIX) | 45,000 | 14,700 | -30,300 | $6.14M | $1.63M | 0.48% | -$4.52M |
| United Therapeutics Corporation(UTHR) | 0 | 5,000 | +5,000 | $0 | $1.54M | 0.45% | +$1.54M |
| Xenon Pharmaceuticals Inc.(XENE) | 40,000 | 40,000 | 0 | $1.57M | $1.34M | 0.39% | -$226.0K |
| Ascendis Pharma A/SADR(ASND) | 7,440 | 7,440 | 0 | $1.02M | $1.16M | 0.34% | +$135.3K |
| Janux Therapeutics, Inc.(JANX) | 162,976 | 38,100 | -124,876 | $8.73M | $1.03M | 0.30% | -$7.70M |
| Mereo BioPharma Group plcADS(MREO) | 421,359 | 421,359 | 0 | $1.47M | $948.1K | 0.28% | -$526.7K |
| Travere Therapeutics, Inc.(TVTX) | 0 | 30,900 | +30,900 | $0 | $553.7K | 0.16% | +$553.7K |
| Centessa Pharmaceuticals PlcADS | 80,380 | 35,226 | -45,154 | $1.35M | $506.6K | 0.15% | -$839.8K |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 7,380 | +7,380 | $0 | $75.7K | 0.02% | +$75.7K |
| Annexon, Inc.(ANNX) | 172,226 | 0 | -172,226 | $883.5K | $0 | — | -$883.5K |
| Charles River Laboratories International, Inc.(CRL) | 6,305 | 0 | -6,305 | $1.16M | $0 | — | -$1.16M |
| Crinetics Pharmaceuticals In | 45,765 | 0 | -45,765 | $2.34M | $0 | — | -$2.34M |
| Enliven Therapeutics Inc | 102,900 | 0 | -102,900 | $2.32M | $0 | — | -$2.32M |
| Newamsterdam Pharma Company ORDINARY SHARES | 54,285 | 0 | -54,285 | $1.40M | $0 | — | -$1.40M |
| Novo Nordisk A/SADR(NVO) | 200,000 | 0 | -200,000 | $17.20M | $0 | — | -$17.20M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 20,811 | 0 | -20,811 | $1.15M | $0 | — | -$1.15M |
| Tectonic Therapeutic, Inc.(TECX) | 16,650 | 0 | -16,650 | $768.7K | $0 | — | -$768.7K |
| Vaxcyte, Inc.(PCVX) | 162,255 | 0 | -162,255 | $13.28M | $0 | — | -$13.28M |